Primary Job Title CEO Primary Organization Iksuda Therapeutics
Location Newcastle, Newcastle upon Tyne, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
After 15 years’ in biologics development and commercialization with Cobra Biologics, Eden Biodesign and Actavis, Dave supported IP Group from October 2011 to develop Glythera's business strategy and fundraising activities. Having co-founded Glythera as Chief Operating officer in March 2012, Dave was appointed CEO in February 2014 and continues
to lead the strategic direction and growth of the business.
